Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2-3
pubmed:dateCreated
1998-10-19
pubmed:abstractText
The involvement of endogenous nitric oxide (NO) in the control of gastric acid secretion induced by some secretagogues was studied in the mouse isolated whole stomach. The gastric acid secretion induced by McNeil A-343 [4-[[[(3-chlorophenyl)amino]carbonyl]oxy]-N,N,N-trimethyl-2-butyn- 1-aminium chloride], a muscarinic M1 receptor agonist, pentagastrin or electrical vagus nerve stimulation was markedly inhibited by pretreatment with the NO synthase inhibitor N(omega)-nitro-L-arginine (L-NNA). This inhibitory effect of L-NNA was reversed by L-arginine, but not by D-arginine. Histamine-induced gastric acid secretion was not influenced by treatment with L-NNA. Famotidine completely inhibited the gastric acid secretion induced by McNeil A-343, pentagastrin or electrical vagus nerve stimulation, showing that these stimulations induced gastric acid secretion mainly through histamine release from histamine-containing cells in the gastric mucosa. Moreover, the pentagastrin- and bethanechol-induced histamine release from gastric mucosal cells was significantly inhibited by L-NNA. The NO donor, sodium nitroprusside, at a concentration not affecting histamine-induced gastric acid secretion, increased the acid secretory response, and this response was inhibited by famotidine. These results suggest that endogenous NO is involved in the gastric acid secretion via histamine release from histamine-containing cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0014-2999
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
350
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
229-36
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9696412-(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium..., pubmed-meshheading:9696412-Animals, pubmed-meshheading:9696412-Electric Stimulation, pubmed-meshheading:9696412-Enzyme Inhibitors, pubmed-meshheading:9696412-Gastric Acid, pubmed-meshheading:9696412-Gastric Mucosa, pubmed-meshheading:9696412-Histamine, pubmed-meshheading:9696412-Histamine Release, pubmed-meshheading:9696412-Male, pubmed-meshheading:9696412-Mice, pubmed-meshheading:9696412-Mice, Inbred Strains, pubmed-meshheading:9696412-Nitric Oxide Synthase, pubmed-meshheading:9696412-Nitroarginine, pubmed-meshheading:9696412-Nitroprusside, pubmed-meshheading:9696412-Pentagastrin, pubmed-meshheading:9696412-Stomach, pubmed-meshheading:9696412-Vagus Nerve, pubmed-meshheading:9696412-Vasoconstrictor Agents
pubmed:year
1998
pubmed:articleTitle
Inhibitory effect of N(omega)-nitro-L-arginine on gastric secretion induced by secretagogues and vagal stimulation in the isolated stomach.
pubmed:affiliation
Department of Drug Evaluation and Toxicological Sciences, Faculty of Pharmaceutical Sciences, Chiba University, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't